97
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Assessment and Comparison of Two Serological Approaches for the Surveillance of Health Workers Exposed to SARS-CoV-2

ORCID Icon, , , ORCID Icon, , , ORCID Icon, ORCID Icon & show all
Pages 4501-4507 | Published online: 17 Dec 2020

References

  • WHO coronavirus disease (COVID-19) Dashboard | WHO coronavirus disease (COVID-19) dashboard. Available from: https://covid19.who.int/. Accessed 99, 2020.
  • Ong DSY, de Man SJ, Lindeboom FA, Koeleman JGM. Comparison of diagnostic accuracies of rapid serological tests and ELISA to molecular diagnostics in patients with suspected coronavirus disease 2019 presenting to the hospital. Clin Microbiol Infect. 2020;26(8):1094.e7–1094.e10. doi:10.1016/j.cmi.2020.05.028
  • Russo A, Minichini C, Starace M, Astorri R, Calò F, Coppola N. Current status of laboratory diagnosis for covid-19: a narrative review. Infect Drug Resist. 2020;13:2657–2665. doi:10.2147/IDR.S26402032801804
  • Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring. J Med Virol. 2020;92(5):464–467. doi:10.1002/jmv.2570232031264
  • Liu R, Liu X, Yuan L, et al. Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis. Int Immunopharmacol. 2020;86:106746. doi:10.1016/j.intimp.2020.10674632619956
  • Zhang M, Jiang Y, Xiao X, Peng M, Peng F, Gong G. Differences in IP-10, TLR4 and IRF5/3 between SVR and non-SVR HCV-1 patients treated with PEG-IFN and ribavirin. Mol Med Rep. 2017;15(4):2318–2324. doi:10.3892/mmr.2017.622928259968
  • Xiang F, Wang X, He X, et al. Antibody detection and dynamic characteristics in patients with COVID-19. Clin Infect Dis. 2020. doi:10.1093/cid/ciaa461
  • Lee HK, Lee BH, Seok SH, et al. Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43. J Vet Sci. 2010;11(1):165–167. doi:10.4142/jvs.2010.11.2.16520458159
  • Grant BD, Anderson CE, Williford JR, et al. SARS-CoV-2 coronavirus nucleocapsid antigen-detecting half-strip lateral flow assay toward the development of point of care tests using commercially available reagents. Anal Chem. 2020;92(16):11305–11309. doi:10.1021/acs.analchem.0c0197532605363
  • Wantai SARS-CoV-2 Rapid test. Beijing Wantai Biological Pharmacy Enterprise C o., Ltd. Beijing, China. Available from: http://www.dbaitalia.it/newsletter/wantai_sars-cov-2_ab_rapid_test_-_ce_ifu.pdf. Accessed 1212, 2020.
  • Macera M, De Angelis G, Sagnelli C, Coppola N. Clinical presentation of covid-19: case series and review of the literature. Int J Environ Res Public Health. 2020;17(14):1–11. doi:10.3390/ijerph17145062
  • Fusco FM, Pisaturo M, Iodice V, et al. COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect. 2020;105(4):596–600. doi:10.1016/j.jhin.2020.06.02132565367
  • Lombardi A, Consonni D, Carugno M, et al. Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy. Clin Microbiol Infect. 2020;26(10):1413.e9–1413.e13. doi:10.1016/j.cmi.2020.06.013
  • Döhla M, Boesecke C, Schulte B, et al. Rapid point-of-care testing for SARS-CoV-2 in a community screening setting shows low sensitivity. Public Health. 2020;182:170–172. doi:10.1016/j.puhe.2020.04.00932334183
  • Montesinos I, Gruson D, Kabamba B, et al. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies. J Clin Virol. 2020;128. doi:10.1016/j.jcv.2020.104413
  • Van Elslande J, Houben E, Depypere M, et al. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect. 2020;26(8):1082–1087. doi:10.1016/j.cmi.2020.05.02332473953
  • Cassaniti I, Novazzi F, Giardina F, et al. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. J Med Virol. 2020;92(10):1724–1727. doi:10.1002/jmv.2580032227490
  • Butner JL, Gupta N, Fabian C, et al. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. J Subst Abuse Treat. 2017;75:49–53. doi:10.1016/j.jsat.2016.12.01428237054
  • Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848. doi:10.1038/s41591-020-0897-132350462
  • Guo L, Ren L, Yang S, et al. Profiling early humoral response to diagnose novel coronavirus disease (COVID-19). Clin Infect Dis. 2020;71(15):778–785. doi:10.1093/cid/ciaa31032198501